Medobar, also known as dobutamine tablets, is indicated for Parkinson’s disease and Parkinson’s syndrome, which can be caused by encephalitis, cerebral infarction and poisoning. Medobar is the most basic and effective therapeutic drug for Parkinson’s and Parkinson’s disease. It is more effective in tremor and limb tonicity and motor retardation. The adult dose of Medobar: for the first week, 125 mg once, twice a day, orally, after which the dose can be increased by 125 mg every other week, usually the daily amount should not exceed 1 g, and can be divided into 3-4 doses. Within 1-5 years of treatment with Medroba, patients have a good outcome, called the “honeymoon period”, which can effectively treat Parkinson’s symptoms. However, with the prolongation of the drug, the effect of Medobar for Parkinson’s will gradually weaken, and some patients with long-term application may also experience motor inability, tremor, and increased myotonicity. Therefore, the best application of Medobar is within the first 5 years, which can have a better effect.